Kevala
Kevala was acquired by Residex®. To see what’s new, visit the Residex® LinkedIn Company Page.
Est 2003|Valuation $52.1M|Raised $16.1M
Published Jun 25, 2026
No explicit public “known issues” page or public roadmap with dates was found for kevala.ai.
Balanced caveat: these points are vendor-asserted; limited third-party reviews and independent validation make it difficult to confirm day-to-day effectiveness, alert accuracy, and…
Most plausible ICP (inferred from PR and senior care multi-site operators):
Decision makers:
End users:
Get a comprehensive analysis of Kevala including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Claims primarily derived from vendor materials (limited independent corroboration):
Balanced caveat: these points are vendor-asserted; limited third-party reviews and independent validation make it difficult to confirm day-to-day effectiveness, alert accuracy, and staff satisfaction outcomes.
Direct Kevala-specific user feedback is scarce in mainstream communities:
Kevala’s website and PR releases include customer quotations and "selected by" announcements (e.g., Charter Senior Living). These are marketing-selected and not independently validated:
Balanced interpretation:
Kevala is a healthcare workforce management and staffing-optimization platform focused on post-acute and senior care. The product emphasizes AI-assisted scheduling, automated shift filling (including callout coverage), credential tracking, and labor-cost controls (e.g., overtime/agency spend monitoring). The vendor describes "Quin" as an AI scheduling agent available continuously that can rebalance schedules, match staff to shifts by policy/credentials/preferences, and surface labor-risk alerts.
Primary target appears to be:
Market positioning: described by the vendor as an AI-based scheduling assistant for staffing optimization and compliance in senior care, positioned to replace spreadsheet-heavy scheduling processes and reduce reliance on agency labor.